The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Evaluation of the adjuvant radiation treatment-effect heterogeneity using genomic signature for locoregional relapse and long-term outcome.
Maggie Chon U Cheang
Other Remuneration - Listed as an inventor on a patent application on the PAM50 molecular assay
Charles M. Perou
Employment or Leadership Position - Bioclassifier LLC/ University Genomics (U); GeneCentric (U)
Stock Ownership - Bioclassifier LLC/ University Genomics; GeneCentric
Other Remuneration - Listed an inventor on a patent application on the PAM50 molecular assay and the VEGF-signature
Timothy Joseph Whelan
No relevant relationships to disclose
Cheng Fan
No relevant relationships to disclose
Tinne Laurberg
No relevant relationships to disclose
David Voduc
No relevant relationships to disclose
Scott Tyldesley
No relevant relationships to disclose
Torsten Nielsen
Consultant or Advisory Role - Bioclassifier (U)
Research Funding - NanoString Technologies
Other Remuneration - Listed as an inventor for a patent application of PAM50 molecular assay
Karen A. Gelmon
No relevant relationships to disclose